Acute lymphocytic leukaemia is a fast-moving cancer of the blood and bone marrow that primarily affects young children, though adults can develop it too. While the diagnosis can be overwhelming, understanding this condition and its treatment options helps patients and families navigate the journey ahead with greater confidence.

What is Acute Lymphocytic Leukaemia?

Acute lymphocytic leukaemia, also known as acute lymphoblastic leukaemia or ALL, is a type of cancer that begins in the bone marrow, the spongy tissue inside bones where blood cells are made. The word “acute” means the disease progresses rapidly and needs quick treatment. “Lymphocytic” refers to lymphocytes, a type of white blood cell that helps the body fight infections.^[1]

In ALL, the bone marrow produces too many immature white blood cells called lymphoblasts or blast cells. These abnormal cells don’t function properly and cannot fight infections effectively. They multiply rapidly and crowd out healthy blood cells in the bone marrow, leaving less room for normal red blood cells, white blood cells, and platelets (cells that help blood clot). This leads to various health problems throughout the body.^[2]

The disease can spread beyond the bone marrow to other parts of the body, including the central nervous system (brain and spinal cord), lymph nodes, liver, spleen, and sometimes the testicles in males. This spreading ability makes ALL particularly serious and requires comprehensive treatment.^[3]

Epidemiology: Who Gets ALL?

Acute lymphocytic leukaemia is relatively rare, making up less than one percent of all cancers in the United States. However, it holds the unfortunate distinction of being the most common type of cancer in children. The disease most frequently affects children between the ages of two and five years old.^[4]

The disease can occur at any age, though, and adults can also develop ALL. The risk pattern follows an interesting age distribution: the highest risk occurs in children under 15 years old, then decreases, and rises again in adults over 50 years of age.^[4]

ALL accounts for approximately two percent of lymphoid cancers diagnosed in the United States each year. In 2025, an estimated 6,100 new cases were expected to be diagnosed, with approximately 1,400 deaths from the disease.^[2][15]

The disease shows some demographic patterns. It occurs slightly more frequently in males than females, with one interesting exception: girls under age one have a higher risk than boys, but after age one, males have the higher risk. ALL is also diagnosed three times more frequently in white populations compared to African American populations.^[2][4]

Causes of Acute Lymphocytic Leukaemia

The exact cause of ALL remains largely unknown, but scientists understand that it develops when bone marrow cells undergo changes, called mutations, in their genetic material or DNA. These mutations disrupt the normal instructions that tell cells how to grow and divide.^[1]

Normally, DNA tells cells to grow at a set rate and die at a set time, maintaining a healthy balance. When mutations occur in bone marrow cells, they may begin producing immature lymphocytes at an abnormal rate. These cells don’t mature properly, don’t die when they should, and continue multiplying uncontrollably. Over time, these abnormal cells accumulate and crowd out healthy blood cells.^[1]

In young children with ALL, these genetic changes may have happened before birth, during foetal development. Some people may also inherit genetic conditions that make them more susceptible to developing ALL later in life. In adults, the disease has been linked to exposure to certain carcinogens (cancer-causing substances), including tobacco.^[4]

It’s important to understand that in most cases, these genetic changes occur randomly and are not passed down from parents to children. The mutations happen in individual cells during a person’s lifetime rather than being inherited.^[2]

Risk Factors

While the exact cause of ALL is unknown, certain factors have been identified that may increase a person’s risk of developing the disease. Having one or more risk factors doesn’t mean someone will definitely get ALL, but it does mean their chances are higher than average.^[2]

Age is one of the strongest risk factors. Children under 15 and adults over 50 face the highest risk. The disease can strike at any age, but these two groups are most vulnerable.^[4]

Certain genetic disorders significantly increase risk. People with Down syndrome, Fanconi anaemia, or other inherited genetic conditions have a much higher chance of developing ALL compared to the general population. These conditions affect how cells grow and divide, making abnormal cell development more likely.^[4]

Previous cancer treatments can paradoxically increase ALL risk. People who have had chemotherapy or radiation therapy for other cancers may later develop ALL as a secondary cancer. This happens because these powerful treatments can damage DNA in healthy cells while destroying cancer cells.^[3]

Exposure to high levels of radiation increases risk. This includes radiation exposure during foetal development in the womb, as well as exposure from radiation therapy or environmental sources. The radiation can cause DNA damage that leads to abnormal cell growth years later.^[4]

Certain viral infections may also play a role in ALL development. Infections with Epstein-Barr virus (which causes mononucleosis) and human T-cell leukaemia virus have been associated with increased risk in some studies.^[4]

Race and ethnicity show some patterns in ALL risk. White populations have a slightly higher risk compared to other racial groups, though the disease can affect people of any background.^[4]

Symptoms and How They Affect Patients

The symptoms of ALL develop because abnormal cells crowd out healthy blood cells in the bone marrow. This leads to three main problems: not enough red blood cells (causing anaemia), not enough normal white blood cells (causing frequent infections), and not enough platelets (causing bleeding problems).^[2]

Many symptoms of ALL resemble those of the flu, which can make early diagnosis challenging. However, unlike flu symptoms that improve within days or weeks, ALL symptoms persist and often worsen over time. This persistence is a key warning sign that something more serious may be happening.^[1]

Fatigue and weakness are among the most common symptoms. People with ALL often feel exhausted even after rest because their bodies lack enough red blood cells to carry oxygen to tissues and organs. This can make everyday activities feel overwhelming and may interfere with work, school, or normal daily routines.^[1]

Frequent infections occur because the abnormal white blood cells cannot fight germs properly. People may experience repeated bouts of fever, persistent infections that don’t respond well to antibiotics, or infections that come back shortly after treatment. The fever may be accompanied by night sweats that drench clothing and bedding.^[2]

Bleeding and bruising problems happen because of low platelet counts. People may notice they bruise easily from minor bumps or develop bruises without remembering any injury. Frequent or severe nosebleeds, bleeding gums when brushing teeth, or unusually heavy menstrual periods in women can occur. Tiny red or purple spots called petechiae may appear on the skin, caused by bleeding under the surface.^[1][4]

Bone and joint pain can develop as leukaemia cells accumulate in the bone marrow, causing pressure and discomfort. This pain may be persistent and aching, affecting the arms, legs, or back. It can be particularly troublesome at night and may interfere with sleep.^[1]

Swollen lymph nodes may appear as painless lumps in the neck, armpits, groin, or abdomen. The liver and spleen may also enlarge, causing a feeling of fullness or discomfort in the upper abdomen. Up to half of adults with ALL notice these symptoms at diagnosis.^[2]

Loss of appetite and unintentional weight loss often occur as the disease progresses. People may lose interest in eating or feel full quickly after eating small amounts. This contributes to the overall weakness and fatigue.^[3]

Pale skin develops due to anaemia. The lack of red blood cells makes the skin, lips, and nail beds appear paler than usual. This pallor is often one of the first signs noticed by family members or friends.^[1]

Shortness of breath may occur with physical activity or even at rest in more advanced cases. This happens because the body doesn’t have enough red blood cells to deliver adequate oxygen to the lungs and other organs.^[3]

When ALL spreads to the central nervous system, additional symptoms may develop. These include severe headaches, nausea and vomiting, blurred or double vision, balance problems, facial muscle weakness or numbness, and seizures. These neurological symptoms require immediate medical attention.^[2][4]

Prevention: Can ALL Be Prevented?

Unfortunately, there are no proven ways to prevent most cases of acute lymphocytic leukaemia. Because the exact cause remains unknown and many cases appear to develop randomly, standard prevention strategies like those used for other cancers (such as lifestyle changes to prevent lung or colon cancer) don’t apply to ALL.^[2]

The genetic mutations that cause ALL typically occur spontaneously during a person’s lifetime rather than being inherited. This random nature makes prevention particularly challenging. Even when risk factors are known, such as previous radiation exposure or certain genetic conditions, there are no specific interventions that can reliably prevent ALL from developing.^[1]

For people with known risk factors, such as inherited genetic disorders like Down syndrome or Fanconi anaemia, regular medical monitoring may help detect the disease earlier if it develops. Early detection can lead to earlier treatment, which may improve outcomes, though this is not the same as prevention.^[4]

Avoiding exposure to high levels of radiation when possible may reduce risk, though most people’s radiation exposure comes from necessary medical procedures where the benefits outweigh the risks. For pregnant women, avoiding unnecessary radiation exposure during pregnancy may theoretically reduce a child’s risk, though most ALL cases in children occur without any identifiable radiation exposure.^[4]

There are no vaccines, dietary supplements, or lifestyle modifications that have been proven to prevent ALL. The focus in managing this disease is on early detection and prompt treatment rather than prevention.^[2]

Pathophysiology: How ALL Changes the Body

To understand how ALL affects the body, it helps to know how normal blood cell development works. All blood cells begin as blood stem cells in the bone marrow. These stem cells can develop into either myeloid stem cells or lymphoid stem cells. Lymphoid stem cells normally mature through several stages to become functional lymphocytes, which are crucial components of the immune system.^[10]

There are three main types of lymphocytes: B lymphocytes (B cells) that produce antibodies to fight infections, T lymphocytes (T cells) that directly attack infected cells and help coordinate immune responses, and natural killer cells that destroy abnormal cells including cancer cells and virus-infected cells.^[10]

In ALL, genetic mutations cause lymphoid stem cells or early lymphocytes to become cancerous. These cells are arrested at an immature stage of development, remaining as lymphoblasts instead of maturing into functional lymphocytes. The immature cells cannot perform normal immune functions, leaving patients vulnerable to infections.^[2]

The disease is classified based on which type of lymphocyte is affected. B-cell ALL affects B lymphocytes and is the most common type, accounting for about 85 percent of childhood cases and 75 to 80 percent of adult cases. T-cell ALL affects T lymphocytes and makes up around 25 percent of adult cases and 12 to 15 percent of childhood cases. A third, very rare type called natural killer ALL also exists.^[4]

The abnormal lymphoblasts multiply uncontrollably in the bone marrow. As they accumulate, they physically crowd out the normal blood-forming cells, reducing the space available for healthy cell production. This leads to decreased production of all three types of normal blood cells: red blood cells, normal white blood cells, and platelets.^[10]

The reduction in red blood cells causes anaemia, leading to fatigue, weakness, pale skin, and shortness of breath. The body’s tissues and organs don’t receive enough oxygen to function properly, affecting energy levels and physical performance.^[2]

The lack of normal, functional white blood cells severely compromises the immune system. Even though the total white blood cell count may be very high in ALL, these cells are immature and useless for fighting infections. Patients become susceptible to bacterial, viral, and fungal infections that can become life-threatening.^[2]

The decrease in platelets leads to bleeding problems. Platelets normally form clots to stop bleeding when blood vessels are damaged. Without enough platelets, even minor injuries can cause prolonged bleeding, and spontaneous bleeding can occur in the gums, nose, or under the skin.^[3]

Leukaemia cells don’t stay confined to the bone marrow. They enter the bloodstream and can travel throughout the body, accumulating in various organs. When they infiltrate the liver and spleen, these organs become enlarged. In the lymph nodes, the accumulation of leukaemia cells causes swelling.^[1]

When ALL spreads to the central nervous system, leukaemia cells can accumulate in the fluid surrounding the brain and spinal cord, or infiltrate the nervous tissue itself. This can increase pressure inside the skull, causing headaches, nausea, vomiting, and vision problems. The cells can also affect individual nerves, causing weakness, numbness, or other neurological symptoms.^[2]

In some cases, ALL cells contain specific genetic abnormalities such as the Philadelphia chromosome, which occurs in about 20 percent of adults with ALL but only a small percentage of children. This chromosome abnormality is created when parts of two chromosomes swap places, creating an abnormal gene that drives cancer cell growth. The presence or absence of this and other genetic abnormalities affects how the disease behaves and how it should be treated.^[15]

The disease progresses rapidly if left untreated. The doubling time of leukaemia cells (how long it takes for their number to double) can be very short, meaning the disease can become life-threatening within three to six months without treatment. This rapid progression is why ALL is considered a medical emergency requiring immediate treatment once diagnosed.^[5]